Haven't used Cell Receptor yet?
Ask Trustburn

Ask Trustburn about Cell Receptor

Based on 10 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Michelle Harris
Reviews 1

I have had mixed experiences with Cell Receptor. Although their customer service is top-notch, the shipping took longer than expected. Nonetheless, the product quality was good. There is room for improvement, but overall, I had a positive experience.

Ben Godgart
Reviews 1

The overall experience with Cell Receptor has been average. The customer service was satisfactory and the product quality was decent. However, there is room for improvement in terms of delivery times and packaging. Overall, an average experience.

Andrew Shepley
Reviews 1

I recently purchased from this website and I'm quite satisfied with my purchase. The website was user-friendly and easy to navigate. The product I received was in good condition and met my expectations. I would recommend it to others.

Questions & Answers

No questions yet β€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website β€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="cellreceptor-ch" data-lang="en"></div>
More widgets

About Cell Receptor

Cell Receptor is a small Geneva based startup company, aiming to establish a new option in the treatment of cancer and autoimmune diseases:

The Cell Receptor team has since 2010 been actively engaged in research on cell proliferation and possesses unique knowledge of a very basic control mechanism of cell growth in our body, that was previously unknown and therefore has not been the subject of therapeutic efforts.

Cell Receptor has also knowledge of groups of pharmacological substances able to interfere with this mechanism, and has, basing thereupon, developed a new method for the prevention of cancer metastases.

The treatment has the potential to inhibit cancer metastasis at very reasonable costs. Therefore, it is expected that the clinical demand and thus the expected sales will be quite substantial.

Cell Receptor will fund a clinical trial as a proof of its concept and is expanding its activities for this purpose.